phrykt

HeartSciences Inc. (HSCS): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of HSCS were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No HSCS insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

HSCS short interest

Low short interest. 2.6% of HSCS shares are sold short: about 1 share in 39. Over the last 12 reports the number of shares short went up 229%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 124,062 HSCS shares were sold short, 2.6% of the shares outstanding, up 96.5% from the report before. At the average daily volume of 90,639 shares, buying them all back would take about 1.4 trading days (days to cover).

Shares short, % of all shares

2.58%May 15Oct 304.38%

Days to cover

1.4May 15Oct 302.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026124,0622.58%+96%90,6391.4
Oct 15, 202663,1461.32%+126%332,1221.0
Sep 30, 202627,9310.58%-30%168,3581.0
Sep 15, 202639,8590.83%-65%131,3261.0
Aug 31, 2026114,1522.93%+125%167,1401.0
Aug 14, 202650,6821.30%-33%66,8431.0
Jul 31, 202676,0301.95%-2%49,2611.5
Jul 15, 202677,6012.44%-37%58,7031.3
Jun 30, 2026123,6403.88%+116%13.68M1.0
Jun 15, 202657,2781.80%+32%62,4801.0
May 29, 202643,4091.36%+15%22,3341.9
May 15, 202637,6721.18%+19%25,9651.4

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

HeartSciences company events

HeartSciences filed 23 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership, listing). The latest was on Nov 6, 2026.

  1. Nov 6, 2026AnnouncementAs previously disclosed, HeartSciences Inc., a Texas corporation, entered into an Agreement and Plan of Merger, dated as of June 23, 2026 (as amended on July 27, 2026, the “ Merger Agreement ”), by and among the Company, Fortitude Mining Holdings, Inc., a Delaware corporation, Fortitude Mining… Filing
  2. Oct 6, 2026AnnouncementShared information with investors. Filing
  3. Oct 2, 2026AgreementAs previously reported, HeartSciences Inc. entered into a Loan and Security Agreement on April 24, 2020, as amended by Amendment No. 1 to the Loan and Security Agreement, dated September 30, 2021, Amendment No. 2 to the Loan and Security Agreement, dated November 3, 2021, Amendment No. 3 to the… Filing
  4. Sep 17, 2026AnnouncementShared information with investors. Filing
  5. Sep 15, 2026ResultsReleased financial results. Filing
  6. Aug 20, 2026AnnouncementShared information with investors. Filing
  7. Aug 19, 2026AnnouncementShared information with investors. Filing
  8. Aug 18, 2026AgreementHeartSciences Inc. sold and issued to Fortitude Mining Holdings, Inc., a Delaware corporation, an aggregate of 411,522 shares of HeartSciences common stock, par value $0.001 per share, at a purchase price of $2.43 per Share in a private placement. Filing
  9. Aug 7, 2026ListingHeartSciences Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that it is not in compliance with the Nasdaq Listing Rule 5550(b)(1) (“Rule 5550(b)(1)”), which requires companies listed on the Nasdaq Capital Market to maintain a… Filing
  10. Jul 29, 2026ResultsReleased financial results. Filing
  11. Jul 27, 2026AgreementHeartSciences Inc., a Texas corporation, entered into Amendment No. 1 to the Agreement and Plan of Merger with Fortitude Mining Holdings, Inc., a Delaware corporation, Fortitude Mining HoldCo, LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of Seller, and Cordis… Filing
  12. Jul 23, 2026AnnouncementShared information with investors. Filing
  13. Jul 10, 2026LeadershipOf this Current Report on Form 8-K (this “ Current Report ”) and is incorporated herein by reference. Filing
  14. Jun 26, 2026LeadershipOf this Current Report on Form 8-K (this “ Current Report ”) and is incorporated herein by reference. Filing
  15. Jun 23, 2026AnnouncementShared information with investors. Filing
  16. Jun 23, 2026LeadershipTo the extent required, the information regarding the Board Change and the Officers Change set forth under Item 1.01 above is incorporated by reference into this Item 5.02. Filing
  17. May 6, 2026VoteReported shareholder vote results. Filing
  18. Apr 3, 2026LeadershipMark Hilz, Chief Operating Officer, Corporate Secretary and member of the Board of Directors of HeartSciences Inc. passed away at the age of 67, f ollowing a period of illness. Filing
  19. Mar 16, 2026ResultsReleased financial results. Filing
  20. Jan 16, 2026AgreementHeartSciences Inc. (the “Company” entered into a Note Purchase Agreement with Streeterville Capital, LLC, an institutional investor, pursuant to which Streeterville purchased from the Company an unsecured promissory note in the amount of $3.6 million, which included an original issue discount of… Filing
  21. Dec 16, 2025AgreementThe Board of Directors of HeartSciences Inc. approved a form of Indemnification Agreement to be entered into with each of its directors and executive officers (each, an “Indemnitee”). Filing
  22. Dec 15, 2025ResultsReleased financial results. Filing
  23. Nov 28, 2025LeadershipOf this Current Report on Form 8-K (this “Current Report”) and is incorporated herein by reference. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

HeartSciences financials

Famous investors that hold HSCS

1 of the 50 well-known investors we track reported holding HSCS in their latest 13F filing. The largest position is Ken Griffin's, worth $64.5K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026185,283$64.5K0.0%-16%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named HSCS in the last 120 days.

FiledHolderFormStake
Oct 28, 2026North Rock Digital, LP13G3.5%
Oct 28, 2026North Rock Digital, LP13G3.5%
Oct 23, 2026Andrew Simpson13D/A7.5%
Oct 23, 2026Andrew Simpson13D/A7.5%

Questions about HeartSciences Inc. (HSCS) stock

Are HSCS insiders buying or selling?

No HSCS insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in HSCS?

As of Oct 30, 2026, 124,062 HSCS shares were sold short, 2.6% of the shares outstanding, up 96.5% from the report before. At the average daily volume of 90,639 shares, buying them all back would take about 1.4 trading days (days to cover). See the history.

Which famous investors hold HSCS?

1 of the 50 well-known investors we track reported HSCS in their latest 13F filing, including Ken Griffin. The largest position is worth $64.5K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.